Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.66 |
| ▸ | LTA4H | P09960 | 1/20 | 0.63 |
| ▸ | LAP3 | P28838 | 2/20 | 0.61 |
| ▸ | ANPEP | P15144 | 1/20 | 0.61 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.61 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ubenimex SCHEMBL7944 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL7943 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL5057802 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL5819609 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL17889224 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL9247599 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL5807154 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL16782424 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL22632072 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP | |
| Ubenimex SCHEMBL5812930 | 1.00 | MME (0.66) | MMELTA4HLAP3ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10696 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081365-A | Alpha-hemolysin recombinant protein and prokaryotic expression method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12616691-B2 | Use of fatty acid oxidation inhibitors as antimicrobials | WASHINGTON UNIVERSITY IN ST. LOUIS (US) | 2026-05-05 | — | — | US | claimed |
| US-12584161-B2 | Stabilization of nucleic acids in urine | STRECK LLC (US) | 2026-03-24 | — | — | US | claimed |
| CN-121575079-A | SGLT1/2 double-target inhibitor, screening method and application thereof, and diabetes treatment drug | 广东药科大学 | 2026-02-27 | — | — | CN | claimed |
| WO-2025217096-A1 | INHIBITORS OF LEUCINE-RICH REPEAT KINASE 2 (LRRK2) AND MEDICAL USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4601653-A2 | COVALENT COMPOUNDS AND USES THEREOF | The General Hospital Corporation (US) | 2025-08-20 | — | — | EP | claimed |
| US-12383554-B2 | Compositions and methods to protect mammalian tissue against cold and other metabolic stresses | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2025-08-12 | — | — | US | claimed |
| US-12364682-B2 | Use of tegaserod in preparation of anti-tumor drug | QINGDAO HAIJI BIOMEDICINE CO., LTD. (CN) | 2025-07-22 | — | — | US | claimed |
| WO-2025132723-A1 | DHP-I INHIBITORS FOR USE AS NEUROPROTECTANTS AND IN THE TREATMENT OF NEUROINFLAMMATORY DAMAGES OF THE VISUAL PATHWAY | TELARA PHARMA S.L. (ES) | 2025-06-26 | — | — | WO | claimed |
| EP-0396560-A1 | PROCESS FOR INCREASING THE GROWTH RATE AND/OR UTILIZATION OF FODDER OR FOODSTUFFS AND/OR RESISTANCE IN ANIMALS AND HUMANS. | TEICHMANN REINHARD K (DE) | 1990-11-14 | — | — | EP | claimed |
| WO-1990005536-A1 | PRODUCTS AND PROCESS FOR INCREASING THE GROWTH RATE AND/OR UTILIZATION OF FODDER OR FOODSTUFFS AND/OR RESISTANCE IN ANIMALS AND HUMANS | TEICHMANN REINHARD (DE) | 1990-05-31 | — | — | WO | claimed |
| EP-0348348-A2 | Process for controlling plant pests | CIBA-GEIGY AG (CH) | 1989-12-27 | — | — | EP | claimed |
| US-4786754-A | HEATING HYGROSCOPIC BESTATIN | Zaidan Hojin Biseibutsu Kagaku Kenkyu Hai (JP) | 1988-11-22 | — | — | US | claimed |
| US-4769490-A | Crystalline gamma-form bestatin and processes for its preparation | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1988-09-06 | — | — | US | claimed |
| US-4711782-A | Prolonged release microcapsules and their production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-12-08 | — | — | US | claimed |
| EP-0187547-A2 | Synthetic polymeric drugs | Ceskoslovenska akademie ved (CS) | 1986-07-16 | — | — | EP | claimed |
| US-4582792-A | COUPLING OF IMMOBILIZED ANTIGEN OR ANTIBODY WITH IMMOBILIZED ENZYME PRODUCT AND MEASUREMENT OF ACTIVITY | FUJIREBIO KABUSHIKI KAISHA (JP) | 1986-04-15 | — | — | US | claimed |
| EP-0083931-A2 | New bestatin-related compounds as immunopotentiator | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1983-07-20 | — | — | EP | claimed |
| US-4029547-A | Biologically active substance, bestatin, and production thereof | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JA) | 1977-06-14 | — | — | US | claimed |